Cancer News and Research

Latest Cancer News and Research

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).

29 Aug 2013

UTHealth professors receives 2013 Distinguished Investigator Award of Academy of Radiology Research

Ponnada Narayana, Ph.D., and Jonathan Ophir, Ph.D., professors in the Department of Diagnostic and Interventional Imaging at The University of Texas Health Science Center at Houston (UTHealth) Medical School, are among recipients of the 2013 Distinguished Investigator Award of the Academy of Radiology Research.

29 Aug 2013

Biostatistician uses statistical and computer modeling for policy development in prostate cancer research

Ruth Etzioni, Ph.D., a biostatistician, is a member of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center.

29 Aug 2013

Fast food TV commercials aimed at children did not comply with self-imposed guidelines

Fast food TV commercials aimed at children 2-11 years old did not comply with self-imposed guidelines organized through the Better Business Bureau (BBB) during a one-year study period, according to Dartmouth researchers who published their findings today with PLOS ONE.

29 Aug 2013

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed - a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

29 Aug 2013

Experts share tips on preventing ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women. Approximately 22,000 women are diagnosed annually and 14,000 die from the disease. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

29 Aug 2013

NAMS publishes new guidance for diagnosing and treating vulvovaginal atrophy

Symptoms of vulvovaginal atrophy (VVA), such as lack of lubrication, irritated tissues, painful urination, and pain with intercourse, affect as many as 45% of women after menopause.

29 Aug 2013

Patient-relevant benefit of PET or PET/CT in oesophageal cancer is still unclear

The patient-relevant benefit of positron emission tomography (PET) in oesophageal cancer, alone or in combination with computed tomography (CT), is not proven due to a lack of comparative studies. In terms of their diagnostic and prognostic accuracy, it also remains unclear whether these diagnostic techniques can detect the spreading of tumours better than conventional diagnostics.

29 Aug 2013

AATS agrees with USPSTF recommendation for lung cancer screening of asymptomatic smokers

The American Association for Thoracic Surgery, a professional organization of surgeons dedicated to the diagnosis, treatment, and cure of diseases of the chest, strongly supports the United States Preventive Services Task Force draft recommendation for lung cancer screening of asymptomatic smokers.

29 Aug 2013

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

While it might be nice to pop a pill to protect your skin from the sun, a Loyola University Health System dermatologist warns that oral sunscreens are not as effective as traditional lotions and creams.

29 Aug 2013

Jia Shen receives 2013 Jess Hay Chancellor's Graduate Student Research Fellowship

Jia Shen, a student at The University of Texas Graduate School of Biomedical Sciences at Houston, is a recipient of a 2013 Jess Hay Chancellor's Graduate Student Research Fellowship. This award is given to two students per year across the entire University of Texas System, which is comprised of nine universities and six health institutions.

29 Aug 2013

ASD children appear to outgrow critical social communication disability

Scientists at Albert Einstein College of Medicine of Yeshiva University have shown that high-functioning autism spectrum disorder (ASD) children appear to outgrow a critical social communication disability. Younger children with ASD have trouble integrating the auditory and visual cues associated with speech, but the researchers found that the problem clears up in adolescence.

29 Aug 2013

Study points to potential new therapeutic target for preventing birth defects in women with diabetes

A research team at the University of Maryland School of Medicine has identified a cell signaling pathway which plays a significant role in causing developmental defects of the fetal spinal cord and brain in babies of women with diabetes.

29 Aug 2013

Research links increased breast cancer risk to more alcohol drinking before motherhood

Here's a sobering fact for millions of young women heading back to school: The more alcohol they drink before motherhood, the greater their risk of future breast cancer.

29 Aug 2013

Tumor vessel density linked to mRCC treatment response

Changes in tumor vessel density correlate with response and resistance to anti-angiogenic therapy in patients with metastatic renal cell carcinoma, study findings suggest.

28 Aug 2013

Muscle density improves mRCC prognosis prediction

Patients with metastatic renal cell carcinoma treated with targeted therapies have a better prognosis if they also have a high quality of muscle, study findings indicate.

28 Aug 2013

Time to RCC recurrence prognostic threshold challenged

A large study confirms the prognostic value of time to recurrence after surgery for renal cell carcinoma, and also suggests the need to reduce the threshold for early recurrence.

28 Aug 2013

Findings support partial nephrectomy for T1b RCC

Partial nephrectomy and radical nephrectomy provide comparable cancer control for T1b renal cell carcinoma, yet use of the less radical approach has remained limited in the USA over recent years, study results show.

28 Aug 2013

Tumor Suppressor May Actually Drive Cancer Development

...

28 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

Cancer News and Research

Latest Cancer News and Research

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

UTHealth professors receives 2013 Distinguished Investigator Award of Academy of Radiology Research

Biostatistician uses statistical and computer modeling for policy development in prostate cancer research

Fast food TV commercials aimed at children did not comply with self-imposed guidelines

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

Experts share tips on preventing ovarian cancer

NAMS publishes new guidance for diagnosing and treating vulvovaginal atrophy

Patient-relevant benefit of PET or PET/CT in oesophageal cancer is still unclear

AATS agrees with USPSTF recommendation for lung cancer screening of asymptomatic smokers

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

Jia Shen receives 2013 Jess Hay Chancellor's Graduate Student Research Fellowship

ASD children appear to outgrow critical social communication disability

Study points to potential new therapeutic target for preventing birth defects in women with diabetes

Research links increased breast cancer risk to more alcohol drinking before motherhood

Tumor vessel density linked to mRCC treatment response

Muscle density improves mRCC prognosis prediction

Time to RCC recurrence prognostic threshold challenged

Findings support partial nephrectomy for T1b RCC

Tumor Suppressor May Actually Drive Cancer Development

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in